Market research
300436.SHE Fujian Cosunter Pharmaceutical Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 15B
- P/E ratio
- Not available
- Analyst target
- 70
- Dividend yield
- Not available
- Beta
- 1.19
Community
Investor discussion
1 comment
Sign in to join the 300436.SHE discussion.
5 years, 5 months ago
Fujian Cosunter Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 1.0% above its 200 day moving average.
From a valuation standpoint, the stock is 43.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 13.8.
Fujian Cosunter Pharmaceutical Co., Ltd's total revenue rose by 5.8% to $98M since the same quarter in the previous year.
Its net income has increased by 94.3% to $-188K since the same quarter in the previous year.
Finally, its free cash flow fell by 98.2% to $-16M since the same quarter in the previous year.
Based on the above factors, Fujian Cosunter Pharmaceutical Co., Ltd gets an overall score of 3/5.